In one paragraphArticle in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
7 authors.
Firas S MidaniAlkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-2473-7758 Heather A DanhofAlkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, Texas, USA.
Nathanael MathewAlkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, Texas, USA.
Colleen K ArdisAlkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, Texas, USA.
Kevin W GareyDepartment of Pharmacy Practice and Translational Research, University of Houston, Houston, Texas, USA.ORCID 0000-0003-2063-7503 Jennifer K SpinlerDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-7830-7665 Robert A BrittonAlkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0001-8983-9539 Funding
Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9MOrganoid Cultivation CoreU19AI157981 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BLUTT, SARAH E · 2021 to 2025
$12.4MResearch Training in Pediatrics GastroenterolgyT32DK007664 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI DOUGLAS G BURRIN · 1991 to 2026
$8.4MDecoding Antibiotic-induced Susceptibility to Clostridium difficile InfectionU01AI124290 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BRITTON, ROBERT A, GAREY, KEVIN W · 2016 to 2020
$7.9MDiet driven evolution of epidemic ribotypes of Clostridium difficileR01AI123278 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BRITTON, ROBERT A · 2018 to 2022
$2.0MMetabolic adaptation drives pathogenicity of C. difficile epidemic strain RT078F32AI136404 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI DANHOF, HEATHER A. · 2019 to 2021
$191kNIAID NIH HHS F32 AI136404NIAID NIH HHS R01 AI123278NIAID NIH HHS U01 AI124290NIAID NIH HHS U19 AI157981
6 · The paper itselfAbstract
IMPORTANCE: The gut pathogen
Indexed as
carbon metabolismClostridioides difficilegrowth modelingribotyping
Identifiers
PMID39185189
PMCPMC11343193
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390